CVRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.69 USD | +2.08% |
|
-1.41% | -53.28% |
| Jan. 31 | CVRx, Inc. Announces Appointment of Kevin Hykes as President, Effective February 12, 2024 | CI |
| Jan. 31 | CVRx, Inc. Announces Chief Executive Officer Changes, Effective February 12, 2024 | CI |
Chart calendar CVRx, Inc.
fc3bb832.Z56QOVaR5nT5tQFa1Fb_8e8349PV0uL_A8Vb33XXi-E.F9r6YRvynh6mzEk34Bqclopmof6Ynqu6SbB2nCaYsqoj2fgOHanLPcjvdg~163387a88d01a14a5fcab92d77680d47
Upcoming events on CVRx, Inc.
Past events on CVRx, Inc.
| 2024-01-25 04:30 pm | Q4 2023 Earnings Call |
| 2024-01-25 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-29 11:00 am | Piper Sandler Healthcare Conference |
| 2023-10-26 05:30 pm | Q3 2023 Earnings Call |
| 2023-10-26 04:15 pm | Q3 2023 Earnings Release |
| 2023-08-10 08:30 am | Canaccord Genuity Growth Conference |
| 2023-07-25 05:30 pm | Q2 2023 Earnings Call |
| 2023-07-25 04:15 pm | Q2 2023 Earnings Release |
| 2023-06-08 10:20 am | William Blair Growth Stock Conference |
| 2023-06-04 | Annual General Meeting |
| 2023-04-27 05:00 pm | Q1 2023 Earnings Call |
| 2023-04-27 04:15 pm | Q1 2023 Earnings Release |
| 2023-03-20 | Technology and Heart FailureTherapeutics Conference |
| 2023-02-21 09:00 am | Business Update Call |
| 2023-01-26 05:30 pm | FY 2022 Earnings Call |
| 2023-01-26 04:15 pm | FY 2022 Earnings Release |
| 2023-01-11 06:45 pm | JP Morgan Healthcare Conference |
| 2022-11-30 08:00 am | Piper Sandler Healthcare Conference |
| 2022-11-16 | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 13,0 13,0 0.28% | 22,5 22,2 1.16% | 39,3 39,2 0.37% | 54,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -25,8 -24,3 -6% | -42,1 -40,6 -3.82% | -36,3 -41,6 12.77% | -38,2 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -26,0 -25,4 -2.04% | -42,5 -42,3 -0.42% | -43,1 -44,8 3.78% | -41,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,0 -41,7 -3.15% | -41,3 -42,5 2.67% | -41,1 -43,6 5.89% | -42,4 |
|
Net income Million USD | Released Forecast Spread | -14,1 | -43,1 -41,5 -3.7% | -41,4 -42,4 2.29% | -41,2 -43,5 5.39% | -41,9 |
|
EPS USD | Released Forecast Spread | -37,2 | -4,16 -4,07 -2.34% | -2,02 -2,06 2% | -1,99 -2,10 5.11% | -1,96 |
| Announcement Date | 09/04/21 | 15/02/22 | 26/01/23 | 25/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,66 3,77 -2.89% | 4,08 3,79 7.58% | 5,03 4,70 7.1% | 6,19 5,68 8.85% | 7,18 6,98 2.85% | 7,98 7,21 10.74% | 9,50 8,58 10.79% | 10,5 9,82 6.99% | 11,3 11,1 2.08% | 11,4 | 13,0 | 14,6 | 15,9 | 16,4 |
|
EBITDA Million USD | Released Forecast Spread | -8,73 -7,78 -12.17% | -9,85 -9,09 -8.32% | -10,9 -10,5 -3.96% | -10,00 -10,5 4.8% | -11,4 -11,0 -2.91% | -10,3 -10,9 5.58% | -10,1 -11,5 11.79% | -7,86 -11,2 29.92% | -7,94 -10,7 25.75% | -10,6 | -10,0 | -8,68 | -9,05 | -4,62 |
|
EBIT Million USD | Released Forecast Spread | -8,79 -8,03 -9.48% | -9,91 -9,68 -2.31% | -11,0 -10,7 -2.99% | -10,1 -11,1 8.94% | -11,5 -11,4 -0.4% | -12,2 -11,5 -5.36% | -11,8 -12,2 3.58% | -9,53 -11,9 19.75% | -9,66 -11,3 14.52% | -11,4 | -10,9 | -10,1 | -9,70 | -5,71 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,5 -9,06 -16.37% | -9,97 -9,87 -0.92% | -11,0 -11,1 0.35% | -9,80 -11,5 14.89% | -10,5 -11,6 9.41% | -11,3 -11,8 3.63% | -11,6 -12,3 5.87% | -8,97 -12,2 26.26% | -9,12 -11,6 21.58% | -11,4 | -11,1 | -10,1 | -9,66 | -5,84 |
|
Net income Million USD | Released Forecast Spread | -10,6 -9,07 -16.59% | -9,99 -9,88 -1.11% | -11,1 -11,1 0.42% | -9,83 -11,5 14.66% | -10,5 -11,6 9.23% | -11,4 -11,8 3.48% | -11,7 -12,4 5.81% | -9,01 -12,2 26.09% | -9,16 -11,7 21.41% | -11,4 | -11,1 | -10,1 | -9,67 | -5,86 |
|
EPS USD | Released Forecast Spread | -0,52 -0,45 -16.85% | -0,49 -0,49 0.21% | -0,54 -0,53 -1.59% | -0,48 -0,56 13.94% | -0,51 -0,56 8.28% | -0,55 -0,57 2.82% | -0,56 -0,58 4.05% | -0,43 -0,58 25.57% | -0,44 -0,55 20.1% | -0,54 | -0,50 | -0,47 | -0,45 | -0,35 |
| Announcement Date | 15/02/22 | 25/04/22 | 28/07/22 | 01/11/22 | 26/01/23 | 27/04/23 | 25/07/23 | 26/10/23 | 25/01/24 | - | - | - | - | - |
| 2024-04-28 | SHENZHEN YHLO BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 2024-05-05 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 2024-05-06 04:09 pm | SI-BONE, INC.: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
Past sector events for CVRx, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CVRX Stock
- Calendar CVRx, Inc.
